Après délibération, le collège de la Haute Autorité de santé, en sa séance du 17 décembre 2020 a constaté l’absence d’évaluation médico-économique du produit COREVALVE EVOLUT R & EVOLUT PRO sur les dépenses de l’assurance maladie.
eNrlWN9v2jAQfu9fgfLuhIR2wBSoNtZuSK3GaNGmvSCTHGBm4tQ/At1fvwuhG52SdTXNU19Q8F2+Ozt33905PN+ueSMDqZhIeo7vNp0GJJGIWbLoOZPbS9Jxzvsn4Ypm9ECt7TZdP3AaEadK9Zxc6s6AJsr9dn31AfB9kE7/pBGK2Qoi/UjPaMbdT1Qtr2ma6zTCTLC4sQa9FHHPSY3erTZCpSV60d8I+UOlNILQ268cSlfT08P10MvB/gPVKJBXNFmUgs6lFWZkpIRED6iGhZD3pdCpjP1p0O288bsdKyNMjUEJIyMYUb0cSZGxGOLybVCuwMrIfBPfgMw46NxIKbi3itbKCpyu6HYMd8Nyp9+hdKC3mjSJ3263/KDTbfl+q2VlSh4cVXn44Ca8dNoKgvZZJ/Dm0oshYnmUk4QEzaBJmq3mmRdHngJQKYkNekVQB9YzCYUGrkWCc1gACginZEmNBoI/QjK9W1Q0wQcJnGqWoYhwQmcKEw2lBDLKDQrQ5hpiFgmCCZSINbszkIOnUsSGaTQic1V8HzLBjSby4QE1LGNpJKSmvKYoYmrwOCNqsiPh7slojZlKOb13Vyq1PSoqKYpBIm/Vt5F8B7cSmRRD5W/8xHDuPdPryZ7navI4p9GBMImuoLvLse1BDASmzLb6i9oxtN7uY5GBejnYnyIpr04jM+MssqVgJEkDSk/Gw2oGfs3k9Z4qmMj62OsrS2KxUS/PiodRWJP36Y7Yy0GjadBpn3Xb9p3Tdwz4ivp9YaRIwUO2ZOoYEhwmc3Es/WEOlUM9ZNCrTZ5d+ysiyqGiASaWzI1Z89Cv15aX9eV8ISgF/XhxaxvOXwzI+5vd31JoFvd+B6JdWaujVmLyVDr+/FQs+Oifo1HBS6edlt1gZGQ53S21TtVbz9tsNu6SqiIjXcz3114+Dzqs+sbIWtq4oq0tilBNrs+K3uJ5EWVLEE81escOL/v390NSqQ0tDRzxLYpaUhvjDy9evoj8mVxqc3v0iPTqM7ObMnYsUlc3aWblt1lHlS38rsmlRIL4PJ+zivu9yrgMveJusX8Sevm9Yv/kF0gw41U=
BbW3VMJ6ghZZ5TuE
